Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives
Year: 2016
Type: review
Institutions: Linköping University, European Society of Clinical Microbiology and Infectious Diseases, Länssjukhuset i Kalmar, Landstinget i Kalmar län, IRCCS Ospedale San Raffaele, IRCCS San Raffaele Roma, University of Cambridge, Unidade de Microbiologia Médica, Universidade Nova de Lisboa, University of Zurich, Inserm, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Université Paris Diderot, Infection, Anti-microbiens, Modélisation, Evolution
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: Mycobacterium tuberculosis, antimicrobial susceptibility testing, drug resistance, multidrug-resistant tuberculosis, extensively drug-resistant tuberculosis, genotypic drug resistance testing, rpoB mutations, rifampicin resistance, hot spot mutations, false resistance, false susceptibility, resistance monitoring, MIC breakpoints, low-income countries
Open Access status: bronze
OpenAlex ID: W2547937482
